Ligand Pharmaceuticals
LGND
#2827
Rank
ยฃ4.38 B
Marketcap
ยฃ219.12
Share price
-3.94%
Change (1 day)
38.91%
Change (1 year)

P/S ratio for Ligand Pharmaceuticals (LGND)

P/S ratio as of November 2026 (TTM): 22.6

According to Ligand Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.93. At the end of 2026 the company had a P/S ratio of 23.8.

P/S ratio history for Ligand Pharmaceuticals from 2001 to 2026

PS ratio at the end of each year

Year P/S ratio Change
202623.870.48%
202514.013.06%
202412.330.17%
20239.4845.3%
20226.53-29.93%
20219.318.57%
20208.58-41.18%
201914.630.16%
201811.2-45.29%
201720.55.1%
201619.5-35.21%
201530.186.35%
201416.1-26.59%
201322.056.36%
201214.180.84%
20117.775.16%
20107.3913.73%
20096.50-31.74%
20089.52-73.03%
200735.3142.56%
200614.6192.86%
20054.97-7.18%
20045.36-29.68%
20037.6291.88%
20023.97-71.82%
200114.1

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Johnson & Johnson
JNJ
6.47-71.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
2.47-89.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
13.9-38.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
6.10-73.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
1.13-95.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
4.86-78.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2.38-89.46%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
2.15-90.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
8.22-63.66%๐Ÿ‡บ๐Ÿ‡ธ USA